Boron neutron capture therapy (BNCT) is based on the ability of the non-radioactive isotope 10 B to capture thermal neutrons and to disintegrate instantaneously. This reaction opens a way to selectively destroy tumour cells after specific uptake of 10 B. In this paper, a method based on electron energy-loss spectroscopy is presented for detecting and quantifying boron in freeze-dried cryosections of human melanoma cells. A practical detection limit of around 6 mmol kg − 1 in 0.1-µ m 2 areas is estimated using specimens prepared from standard boron solutions. Preliminary results of boron mapping in the spectrum-imaging acquisition mode reveal boron penetration and probably spot-like accumulation within melanoma cells when exposed to culture medium containing sodium borocaptate.
Introduction
Boron neutron capture therapy (BNCT) is based on the ability of the non-radioactive isotope 10 B to capture thermal neutrons and to disintegrate instantaneously producing two high linear energy transfer (LET) particles, He and Li nuclei, with high kinetic energies of about 2.7 MeV and a very short range within tissue of about 10 µ m [ 10 B(n, α ) 7 Li]. The cross-section for this reaction of 3838 barns is relatively high, where 1 barn = 10 − 28 m 2 . This reaction opens a way to destroy tumour cells selectively after specific uptake of 10 B. Principles, problems and perspectives of BNCT are reviewed in details elsewhere (Sauerwein, 1993; Dorn, 1994; Barth et al ., 1996; IAEA, 2001) .
Already in the 1950s and 1960s, the first clinical BNCT trials were performed with disappointing results owing to inadequate boron-compounds and suboptimal understanding of the resulting dose distributions. Further pioneering clinical work was done in Japan. In the early 1990s a resurgence of BNCT activity occurred both in the USA and in Europe, which led to the start of new trials at Brookhaven National Laboratory (BNL) and the Massachusetts Institute of Technology (MIT), as well as at the European research reactor HFR in Petten (Diaz et al ., 2000; Kiger et al ., 2001; Sauerwein et al ., 2001; Wittig et al ., 2002) . Recently, clinical applications have also started in Finland, the Czech Republic and Sweden. Most of these trials are Phase I studies with the principal aim of establishing the maximum tolerated dose and the dose-limiting toxicity under defined conditions. At the European level, supported within the FP 5 programme of the European Commission, a clinically orientated project called 'Boron Imaging' is underway. Here we present some methodological results involving this project that are related to the use of electron energy-loss spectroscopic imaging to map subcellular boron distributions.
To promote BNCT as a new clinical modality, a binary treatment has to be handled. A drug, susceptible to target tumour cells, has to deliver the isotope 10 B selectively. Furthermore, a high intensity of thermal neutrons has to be applied to the tumour. Such radiation beams that can only be generated by nuclear reactors produce a complex dose distribution in tissue due to components produced not only by the boron neutron capture reaction but also from incident fast neutrons and gamma rays, and other components produced by capture of thermal neutrons within the irradiated volume. The latter dose contributions will not be selective to the targeted tumour. The major dose component from the 10 B(n, α ) 7 Li reaction can actually not be described by the conventional concept of absorbed dose because the energy released in matter by the α and Li particles is distributed inhomogeneously in a subcellular volume. As the range of the fission fragments is relatively small, the clinical efficacy of the therapy strongly depends on the localization of the 10 B inside individual cells. If it is localized in a sensitive area, i.e. closely to the cell nucleus, a very high efficiency of the treatment will result. The same amount of 10 B in the same cell but distributed homogeneously through the cytoplasm will give a completely different (and less effective) response to the same neutron irradiation. Thus, an important requirement to develop BNCT and to understand the effects of this binary modality is the development of tools to image and quantify the boron concentration, and particularly the boron distribution within individual cells.
Principles and motivations of electron energy-loss spectroscopy of freeze-dried cryosections
Until now for the purposes of BNCT 10 B was quantitatively determined in volumes that were always bigger than the range of the high LET particles intended to be used for cancer treatment. Owing to the inhomogeneous distribution of the 10 B-compounds at microscopic level, the results of such measurements integrated over a bigger volume than the irradiated volume cannot predict reliably the radiation effect. However, to evaluate different boron uptake in several tissues and tumours, inductively coupled plasma (ICP) atomic emission spectrometry (ICP-AES), mass spectrometry (ICP-MS) or laser ablation-ICP-MS are widely used to obtain a rapid and sensitive determination of mean concentration of boron in biological samples (Pollmann et al ., 1993; Probst, 1999) . Secondary ion mass spectroscopy (SIMS) or high-resolution alpha autoradiography are also used for imaging boron distributions at the cellular level (Solares & Zamenhof, 1995; Smith et al ., 2001 ).
Electron energy-loss spectroscopy (EELS) may be a method for subcellular analysis due to its capacity for high spatial resolution. EELS is an analytical technique with theoretical subnanometre spatial resolution (Mory et al ., 1991) . The effective resolution is often a few tens of nanometres limited not by the probe resolution but by the sample itself. Indeed, a sample has to provide a sufficient analytical signal-to-noise ratio, while avoiding severe radiation damage due to the incident electron dose. It is well established that EELS is the most sensitive nano-analytical technique for detecting light elements such as carbon, oxygen or nitrogen in a biological tissue (Isaacson & Johnson, 1975; Leapman & Ornberg, 1988) . However, these elements are ubiquitous in the tissues and therefore high sensitivity is generally not required for analysis. On the other hand, the efficiency of EELS to analyse light elements can be a powerful tool to estimate the subcellular boron distribution. In this sense, a recent publication by Zhu et al . (2001) deals with boron detection in a carbon matrix and boron mapping in a boron-stained tobacco mosaic virus (TMV) sample.
In the present work, we present a method for boron measurements in typical biological cryosections and its application to boron mapping in samples relevant to BNCT. It should be emphasized that boron detection by EELS is of course independent of the isotopic form of the element. EELS is a spectroscopic technique based on the inelastic scattering of incident fast electrons that can be coupled to transmission or scanning transmission electron microscopy (TEM/STEM). Boron can be detected by ionization of K shell levels resulting in a signal with a threshold at ∆ E = 188 eV in the energy-loss spectrum. This characteristic signal is superimposed on a non-characteristic background signal. In biological samples the signal-tobackground ratio of trace elements is very low.
One major problem concerns background subtraction because a small uncertainty in the background estimation induces a large error in the evaluation of the net signal. EELS elemental quantification can be carried out by recording spectra from specific areas of the specimen defined by the STEM image. In the spectrum-imaging acquisition mode, a spectrum is collected from each pixel in a defined STEM image area ( Jeanguillaume & Colliex, 1989; Balossier et al ., 1991; Hunt & Williams, 1991) . In order to reveal and quantify the elemental signal, each spectrum can then be processed with powerful methods such as multiple least-squares fitting and/or digital filtering as presented in this paper. Measured signals can then be presented as elemental maps to be correlated with the STEM image. Moreover, adding up the different spectra recorded in a particular cell compartment allows highly sensitive quantification.
Previous studies (Bendayan et al ., 1989; Autry et al ., 1997; Otersen et al ., 1997) of boron imaging in cells or tissues have been carried out by electron spectroscopic imaging (ESI), which is an imaging technique coupled with energy-filtering transmission electron microscopy (EFTEM). As for EELS, the ESI technique is based on inelastic scattering of the incoming electrons by a sample, but in this case it is a transmission image from electrons that suffer a specific energy loss. ESI presents the advantage of rapid imaging of large sample areas.
Classically, ESI elemental mapping is performed by means of the three-window algorithm method. In this approach, two energy-filtered images are recorded at energy losses below the boron K edge threshold. These images are used to estimate the background, which is then subtracted from the energy-filtered image recorded at an energy loss just above the boron K edge threshold. This method is particularly suited for imaging and qualitative analysis when the relevant signal-to-background ratio is high enough and when background slope can be easily modelled. As will be presented here, signal-to-background ratios for boron in BNCT relevant samples are usually very weak. In these cases, ESI classical mapping is unsuitable for quantification and must be performed very carefully to avoid errors due to underestimating the local variation of the background slope. Many parameters can change the background slope in the boron signal area: multiple scattering effects caused by sample thickness variations, tails of phosphorus and sulphur L 2,3 edges located at 132 eV and 165 eV, respectively. Moreover, the phosphorus L 1 edge is at approximately the same energy as the boron K edge. ESI can also lead to unbiased quantitative results provided a sufficient set of images is recorded. In this case, an equivalent energy-loss spectrum can be created for each image pixel. This method, called imagingspectrum, has been presented and discussed by Lavergne et al . (1992) . However, it suffers from a lack of energy resolution as compared to the STEM/EELS acquisition mode. Moreover, when an ESI filtered image is recorded at a precise energy loss, the rest of the energy loss signal is lost which is not the case with the STEM/EELS acquisition mode.
Another critical parameter for the study of elemental distributions in cells and tissues is the sample preparation for electron microscopy. Preparation techniques have to preserve the cellular structure and the distribution of substances as close as possible to the living state of cells or tissues. Conventional preparation methods are based on chemical fixation by aldehydes, staining by heavy metals, dehydration in alcohol and plastic embedding. These treatments cause loss and redistribution of diffusible substances. Therefore, conventional preparation methods cannot be used for the localization of mobile elements. The alternative, used in this experiment, is a cryopreparation method that avoids any chemical treatment during the preparation process in order to immobilize diffusible substances close to their position in the native state (Zierold, 1991; Zierold et al ., 1994) . Cryofixation followed by cryoultramicrotomy, cryotransfer and freeze-drying preserves the original elemental distribution in the specimen until measurement in the electron microscope. Progress in subcellular element localization may sometimes be achieved at the expense of specimen morphology observed in the electron microscope. For example, cryofixation may cause ice crystal damage of subcellular structures, and the avoidance of chemical staining may result in weaker image contrast.
Materials and methods

Specimen preparation
Electron energy-loss spectroscopy (EELS) was used to measure the subcellular boron distribution in cell cultures, as delivered by 10 B-enriched sodium borocaptate, Na 2 B 12 H 11 SH (BSH), purchased from Centronic Ltd, Croyden, Surrey, U.K. (Soloway et al ., 1967) . BSH is used in clinical trials as a promising target compound for BNCT for treatment of brain tumours. Due to its high boron content of 57% w/w, a relatively high local concentration of 10 B can be achieved. We used cultured human melanoma cells (MeWo) for measuring the boron distribution because these cells were studied previously to evaluate cytotoxicity of boronated drugs (Wittig et al ., 1998) .
Cryopreparation was employed to preserve the distribution of intracellular substances, in particular BSH, as close as possible to the experimental state until investigation in the electron microscope. To validate the quantification process and to estimate detection sensitivity, we also prepared mixtures of dextran and boric acid solutions (Fluka, Saint-Quentin Fallavier, France) in the boron concentrations series 20, 50, 100 and 400 mmol kg − 1 dry mass. Cultured human melanoma cells (MeWo) were exposed to the boron compound (BSH) at a 10 B concentration of 600 p.p.m. for 24 h as described previously (Wittig et al ., 1998) . Cells were detached from the culture flask by trypsin and either taken up in medium containing BSH or in BSH-free medium. After centrifugation, droplets of cell suspension were cryofixed by rapid immersion into liquid propane cooled by liquid nitrogen. Cryosections of approximately 80 nm thickness were prepared by cryoultramicrotomy at a temperature below 160 K (Zierold, 1988) . The sections were placed on electron microscope grids with a network-like support film (lacey film) in order to prevent any interaction of the electron beam with specimen support or evaporation layer. Cryosections were stored in liquid nitrogen until cryotransfer into the Philips CM 30 electron microscope by means of a Gatan cryotransfer system. The sections were freeze-dried by raising the temperature to 193 K for 1 h, after which electron microscope investigations were done at a temperature below 110 K. The morphology of cryosections from MeWo cells on lacey film is illustrated in Fig. 1 . The same cryopreparation technique was used for droplets of standard solutions.
Specimen analysis
Spectra were recorded by means of a Gatan model 666 electron energy-loss spectrometer equipped with a parallel detector consisting of a 1024-channel photodiode array. Standard preliminary processing procedures were performed on each collected spectrum, i.e. overall correction for gain variations and dark-current subtraction, and correction for linearity of the intensity scale (Egerton et al ., 1993) . With an energy dispersion of 0.5 eV/channel, spectra extend typically over a few hundred eV along the energy-loss axis. Boron was identified in the cells by its characteristic K edge at 188 eV in the energyloss spectrum. Figure 2 presents two raw spectra recorded, respectively, on an extracellular medium precipitate (Fig. 2a) and on a MeWo cell treated with BSH (Fig. 2b) . In this energyloss region, the major background component is the tail of the plasmon peak due to inelastic scattering from valence electrons. In biological sections, tails of phosphorous and sulphur L 2,3 edges and phosphorous L 1 edge may also be superimposed. EELS spectra were quantified by forming the boron/carbon atomic ratio (B/C) from the electron energy-loss spectra according to the formula of Egerton (1996): where S 1 ( ∆ , β ) represents the single scattering signals measured in the spectra and σ ( ∆ , β ) the cross-sections for inelastic scattering from shell K. Indices B and C refer to boron and carbon, respectively. ∆ and ∆′ are the energy integration windows and β is the angular acceptance of the spectrometer.
The carbon signal, identified by the characteristic K edge at 284 eV, was extracted from the non-characteristic background by the background fitting method using the conventional power law energy dependence ( AE -r ) (Egerton, 1996) . A deconvolution process was then applied to this extracted signal in order to estimate the single scattering signal. In the case of boron in a biological tissue, the power law model for the background in the plasmon tail region is not sufficiently accurate when the signal to background ratio is low. Under these conditions a small uncertainty in the background estimation induces a large relative error in the evaluation of the boron signal. As an illustration, Fig. 3(b) presents the extraction from the raw spectrum in Fig. 3 (a) of a negative boron signal by fitting an AE -r background in the energy range 160-180 eV. Therefore, the boron signal was extracted by digital filtering (Bonnet et al ., 1992; Michel et al ., 1993) and more precisely by derivative gaussian digital filtering, which has recently been described (Michel & Bonnet, 2001 ) and which allows complete removal of the background component. Figure 3(c) shows the output from the raw spectrum in Fig. 3(a) of a fourth derivative Gaussian filter. The boron signal is then quantified by a weighted multiple least-squares fitting process (Bevington, 1969; Shuman & Somlyo, 1987; Leapman & Swyt, 1988; Feng et al ., 1999) . We minimize the sum of the weighted least-squares differences between the experimental filtered spectrum and a boron-filtered reference spectrum. Then the fitting coefficient allows determination of the boron signal. Moreover, the standard deviation of the fitting coefficient may be used to estimate the detection sensitivity. In the presence of phosphorus, we also have to take into account the filtered phosphorus L 1 signal, which is located at an energy loss of 189 eV close to the energy loss of the boron K edge. So in the boron energyloss region, the experimental filtered spectrum S exp,F ( E ) has to be modelled as a sum of a boron-filtered reference spectrum S B,F ( E ) and a phosphorus-filtered reference spectrum S P,F ( E ): 
EELS measurements combined with energy-dispersive X-ray spectroscopy (EDXS) to control cell viability or cell membrane damage of cells exposed to BSH by simultaneous measurement of intracellular K/Na ratios (Zierold, 1991) . When there is membrane damage and/or reduced cell viability, the intracellular K/Na ratio is known to be appreciably lower than when the cells are undamaged. X-ray spectra were recorded by means of an EDAX 30-mm 2 Si(Li) R-SUTW detector.
Results and discussion
Cryosections of standard solution were analysed at an accelerating voltage of 250 kV with a probe size of 25 nm and an incident electron dose of approximately 7 × 10 7 electrons nm − 2 ( t = 3 s, i = 1.8 nA). For each standard solution, we recorded and added up spectra (16*16 in the spectrum-imaging acquisition mode) in different 0.1-µ m 2 areas. In order to minimize the short-range gain fluctuations between photodiode elements, different spectrum-image lines were recorded with different energy offsets and, prior to adding up spectra, they were superimposed using a maximum correlation coefficient computation. Figure 4 presents the sum of 256 spectra from a 50-mmol kg − 1 boron standard cryosection (Fig. 4a) , the corresponding filtered spectrum and its multiple least-squares fitting (Fig. 4b) . The corresponding ratio between the fitting coefficient and its standard deviation ( a / σ a ) is around 24. Figure 5 presents the calibration curve, showing good agreement between the nominal concentrations and the measured concentrations. We define the signal-to-noise ratio as the ratio between the extracted signal and its standard deviation (Egerton, 1996) , and consider a minimum permissible signal-to-noise ratio of 3. The detection sensitivity under these experimental conditions is estimated at around 6 mmol kg
, based on the different experimental values of a / σ a . As an illustration, Fig. 6 is the filtered spectrum and its multiple least-squares fit corresponding to the sum of 256 spectra from a standard cryosection that contains 20 mmol kg − 1 boron. In a clinical situation (EORTC trial 11961), BNCT is performed at a 10 B-concentration of 30 p.p.m. in blood, assuming that the blood boron concentration would be equal to the boron concentration in the tumour tissue (Hideghéty et al ., 1999) . Therefore, the above mentioned result for detection sensitivity is significant since a tumour boron concentration of approximately 30 µ g 10 B g − 1 would correspond to approximately 180 p.p.m. in the freeze-dried cryosections. This would be equivalent to 15 mmol boron kg − 1 , assuming a 55% dry mass fraction for carbon (Leapman et al ., 1993) , which is greater than our estimated detection limit in a 0.1-µ m 2 area. Furthermore, boron concentrations are related to isotopes 10 B and 11 B and consequently are above 30 µ g g − 1 . In other respects, 30 µ g 10 B g −1 is an average value, and local concentrations could largely exceed this value in the case of a nonuniform boron distribution in individual cells and especially in the case of localized boron accumulation. Thus EELS is particularly useful for revealing possible inhomogeneities of the boron distribution within individual cells.
Since experimental conditions and samples are different, comparison with the results of Zhu et al. (2001) for detection limit sensitivity is not straightforward. These authors calculate, for an ideal detector, a detection sensitivity of 1700 p.p.m. with a 10% accuracy criterion at a total electron dose of approximately 2.6 × 10 10 electrons. Their calculations are based on an AE -r model for background extrapolation. They take into account a statistical uncertainty in the background estimation parameters (Egerton, 1982) but assume that the model is correct, which is not always valid in our biological specimen (see Fig. 3 ). If we extrapolate these authors' estimation for a total electron dose of 8.2 × 10 12 electrons, corresponding to our total electron dose, and an accuracy criteria of 33%, we find a detection sensitivity of 29 p.p.m. equivalent to approximately 3 mmol kg −1 in a typical freeze-dried biological cryosection. It appears that despite significant methodological and experimental differences, the detection sensitivity estimations are within the same range of values.
In biological tissues and especially in the nucleus of the cell, phosphorus is a ubiquitous element. Figure 7 presents a filtered spectrum from a phosphorus-rich area showing the L 2,3 and L 1 edge filtered signals. It is important to point out that shapes and energies of phosphorus L 1 edge filtered signal and boron K-edge filtered signal are rather similar. Therefore, it appears difficult to determine practically both coefficients a B and a P by fitting the boron K edge region. For instance, by using this process, a P values that are similar to the a B values may be obtained in boron standard solutions without phosphorus and on the other hand significant boron signals in cells may be obtained without BSH treatment. We then measured independently the a P coefficients by a multiple least-squares fitting process in the phosphorus L 2,3 region. In this way, boron signals measured in boron standard solutions did not change significantly between quantification processes with or without phosphorus coefficients. The maximum boron signal variation obtained in the 20 mmol kg −1 boron standard was around 6%. On the other hand, we did not detect any significant boron in untreated cells. Nevertheless, it must be emphasized that the presence of phosphorus will always limit the boron detection sensitivity as a function of phosphorus concentration. Quantitative boron measurements have to be performed using a P values but also a P ± 3σ a values in order to estimate the uncertainty of the boron signal.
According to EDXS measurements, the analysed cells can be separated in two types, cells in which the K/Na ratio is below 1 : 1 and cells in which the K/Na ratio is higher than about 5 : 1. Very high boron concentrations up to a few thousand mmol kg −1 and rather homogeneous boron distributions are often measured in cells characterized by low K/Na ratios, probably due to damage of cell membranes. Boron measurements in these damaged cells have no biological significance but it is important to identify them in cryosections.
In this paper, we present preliminary results on boron distributions in undamaged cells characterized by high K/Na values. Figure 8 presents typical elemental maps corresponding to an identified region of a cryosectioned cell that is observed in dark-field STEM. The elemental maps correspond to 64 × 64 pixels in the spectrum-imaging acquisition mode. The pixel size is 60 nm and the electron dose is around 5.7 × 10 6 electrons nm −2 (t = 1 s, i = 2.6 nA). As expected, boron is essentially located as precipitates in the extracellular medium. However, the boron map also reveals intracellular boron signals and consequently boron (BSH) penetration into individual cells. These significant intracellular signals are spatially limited to a few pixels. Figure 9 presents the filtered spectrum and its multiple least-squares fit corresponding to the pixel (X = 2, Y = 3). Quantification for this pixel leads to a B/C-value of 0.02, which corresponds to 920 mmol kg −1 . These results were repeated in different boron maps of cryosectioned cells. From these results, we tentatively conclude that there is some evidence for penetration of boron, and therefore BSH, inside individual MeWo cells. Moreover, intracellular boron seems to be accumulated at relatively high concentrations, a few hundred mmol kg −1 , in small areas that are not yet morphologically defined. It must be pointed out that more measurements must be made to complete statistical studies and draw conclusions for the clinical modality BNCT.
Conclusions
EELS combined with cryo-methods might be a suitable method for imaging boron in BNCT studies provided sufficient care is taken to process the data. There is some evidence for boron penetration and possible accumulation in small regions inside MeWo cells when they are exposed to culture medium containing BSH. It will be important to study boron retention after replacing the cell culture medium with fresh BSH-free medium. Other molecules such as the borocaptate dimer Cs 4 B 24 H 22 S 2 (BSSB) have also to be studied. Elhanati et al. (2001) have shown by means of 11 B nuclear magnetic resonance spectroscopy that BSSB presents a strong retention in malignant cells. Finally, an important prospect of the method presented here is for the subcellular boron quantification in tumour and surrounding tissues in patients, which implies further developments in sampling and associated cryomethods.
